feed,title,long_url,short_url
Benzinga,Iovance Shares Jump After Lifileucel Achieves 86% Response Rate In Melanoma Trial,https://benzinga.com/general/biotech/21/05/21220023/iovance-shares-jump-after-lifileucel-achieves-86-response-rate-in-melanoma-trial,https://j.mp/3ox6uYb
